This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thermo Fisher Scientific Inc (TMO)

NYSE: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 16.89B 13.09B 12.51B 11.73B
Cost of Sales 7.71B 6.56B 6.23B 6.05B
Gross Operating Profit 9.18B 6.53B 6.28B 5.68B
Selling, General, and Administrative Expenses 4.90B 3.45B 3.35B 3.13B
Research & Development 691.10M 395.50M 376.40M 340.60M
Operating Income before D & A (EBITDA) 3.59B 2.69B 2.55B 2.21B
Depreciation & Amortization 1.68B 999.90M 983.70M 863.50M
Interest Income 47.70M 28.00M 25.20M 26.90M
Other Income - Net 16.40M -56.00M 3.70M 29.80M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 2.57B 1.58B 1.51B 1.30B
Interest Expense 479.90M 262.10M 241.60M 175.30M
Pre-Tax Income 2.09B 1.32B 1.27B 1.13B
Income Taxes 191.70M 40.40M 11.00M 107.00M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 1.90B 1.28B 1.26B 1.02B
Net Income From Discontinued Operations -1.10M -5.80M -80.50M 310.30M
Net Income From Total Operations 1.89B 1.27B 1.18B 1.33B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.89B 1.27B 1.18B 1.33B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.30B 1.36B 1.34B 1.12B
Preferred Dividends
Net Income Available To Common 1.90B 1.28B 1.26B 1.02B
Basic EPS from Continuing Ops. 4.76 3.55 3.46 2.68
Basic EPS from Discontinued Ops. 0.00 -0.02 -0.22 0.81
Basic EPS from Total Operations 4.76 3.53 3.24 3.49
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 4.76 3.53 3.24 3.49
Basic Normalized Net Income/Share 3.26 3.77 3.69 2.94
EPS fr Continuing Ops. 4.71 3.50 3.43 2.65
EPS fr Discontinued Ops 0.00 -0.02 -0.22 0.81
EPS fr Total Ops. 4.71 3.48 3.21 3.46
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 4.71 3.48 3.21 3.46
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.22 3.71 3.65 2.91
Dividends Paid per Share 0.60 0.60 0.54 0.00
TMO News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

TMO Thermo Fisher Scientific Inc

Chart of TMO

Analysts Ratings for TMO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 14 14 13 13
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET TMO ANALYST REPORT

TMO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs